Archaea methanogens are associated with cognitive performance through the shaping of gut microbiota, butyrate and histidine metabolism
Open Access
- 5 February 2025
- journal article
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2455506
Abstract
The relationship between bacteria, cognitive function and obesity is well established, yet the role of archaeal species remains underexplored. We used shotgun metagenomics and neuropsychological tests to identify microbial species associated with cognition in a discovery cohort (IRONMET, n = 125). Interestingly, methanogen archaeas exhibited the strongest positive associations with cognition, particularly Methanobrevibacter smithii (M. smithii). Stratifying individuals by median-centered log ratios (CLR) of M. smithii (low and high M. smithii groups: LMs and HMs) revealed that HMs exhibited better cognition and distinct gut bacterial profiles (PERMANOVA p = 0.001), characterized by increased levels of Verrucomicrobia, Synergistetes and Lentisphaerae species and reduced levels of Bacteroidetes and Proteobacteria. Several of these species were linked to the cognitive test scores. These findings were replicated in a large-scale validation cohort (Aging Imageomics, n = 942). Functional analyses revealed an enrichment of energy, butyrate, and bile acid metabolism in HMs in both cohorts. Global plasma metabolomics by CIL LC-MS in IRONMET identified an enrichment of methylhistidine, phenylacetate, alpha-linolenic and linoleic acid, and secondary bile acid metabolism associated with increased levels of 3-methylhistidine, phenylacetylgluamine, adrenic acid, and isolithocholic acid in the HMs group. Phenylacetate and linoleic acid metabolism also emerged in the Aging Imageomics cohort performing untargeted HPLC-ESI-MS/MS metabolic profiling, while a targeted bile acid profiling identified again isolithocholic acid as one of the most significant bile acid increased in the HMs. 3-Methylhistidine levels were also associated with intense physical activity in a second validation cohort (IRONMET-CGM, n = 116). Finally, FMT from HMs donors improved cognitive flexibility, reduced weight, and altered SCFAs, histidine-, linoleic acid- and phenylalanine-related metabolites in the dorsal striatum of recipient mice. M. smithii seems to interact with the bacterial ecosystem affecting butyrate, histidine, phenylalanine, and linoleic acid metabolism with a positive impact on cognition, constituting a promising therapeutic target to enhance cognitive performance, especially in subjects with obesity.Keywords
Funding Information
- the European Regional Development Fund
- the Biotechnology and Biological Sciences Research Council
This publication has 82 references indexed in Scilit:
- A multi‐omics study to monitor senescence‐associated secretory phenotypes of Alzheimer's diseaseAnnals of Clinical and Translational Neurology, 2024
- Archaea from the gut microbiota of humans: Could be linked to chronic diseases?Anaerobe, 2022
- Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal womenJournal of Cachexia, Sarcopenia and Muscle, 2021
- Bacteria and Methanogens in the Human Microbiome: a Review of Syntrophic InteractionsMicrobial Ecology, 2021
- Differences in fecal microbial metabolites and microbiota of children with autism spectrum disordersAnaerobe, 2018
- Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeMovement Disorders, 2017
- Human gut microbiota: the links with dementia developmentProtein & Cell, 2016
- Gut colonization with methanobrevibacter smithii is associated with childhood weight developmentObesity, 2015
- Validity of 3-methylhistidine excretion as an indicator of skeletal muscle protein breakdown in humansMetabolism, 1988
- Metabolism of 3-methylhistidine in manMetabolism, 1975